Theodoros Karantanos

22PUBLICATIONS
61CO-AUTHORS
Haematological tumoursMedical molecular engineering of nucleic acids and proteinsMolecular targetsAutoimmunityMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Feb 15, 2026
Chemotherapy regimens with second generation tyrosine kinase inhibitors for BCR-ABL B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation.

John Preston Claiborne, Hua-Ling Tsai, Gabriel Ghiaur

|Nov 27, 2025
Molecular and Clinical Insights into TP53-Mutated MDS and AML.

Erotokritos Georgantzinos, Theodoros Karantanos

|Sep 02, 2025
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML.

Nour Sabiha Naji, Taha Ahmedna, J David Peske

|May 14, 2025
Unraveling Venetoclax Resistance: Navigating the Future of HMA/Venetoclax-Refractory AML in the Molecular Era.

Theodora Chatzilygeroudi, Theodoros Karantanos, Vasiliki Pappa

|Mar 10, 2025
CCRL2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated TP53.

Nour Sabiha Naji, Sergiu Pasca, Theodora Chatzilygeroudi

|Dec 17, 2024
Inflammation and Related Signaling Pathways in Acute Myeloid Leukemia.

Nour Sabiha Naji, Mrudula Sathish, Theodoros Karantanos

Pageof 4

Frequent Collaborators

4 joint publications

Nour Sabiha Naji

4 joint publications

Styliani Karanika

3 joint publications

Alison R Moliterno

3 joint publications

Tania Jain